News

To emerge stronger from the pandemic than entering it, we have for the time being focused our resources on reducing sales cost, improving our market visibility and expanding the HoloMonitor product line.

The National Institute on Aging and PHI recently entered a collaboration agreement, aiming to develop an add-on fluorescent module for PHI’s HoloMonitor imaging cytometer.

To bridge and adapt to the consequences of the COVID-19 pandemic, PHI has received a binding credit facility of 15 MSEK.

As the dust from the stampede of bewildered politicians and overconfident billionaires settles, we begin to discern the new world shaped by the COVID-19 pandemic.

With permanent staff on the ground in the US, we will be able to prepare, train and support a US sales organization much more efficiently than what was previously achievable.

Gladstone Institutes, University of California in San Francisco and PHI recently formed San Francisco’s Center of Excellence for Holographic Imaging Cytometry.

PHI recently joined forces with the Huntsman Cancer Institute in the battle against cancer.

In the article published today by BioStock, the company's CEO Peter Egelberg comments on the developments during the past autumn.

PHI’s CEO and founder Peter Egelberg comments the recently published innovation report from the UN agency World Intellectual Property Organization.

Interim Report 2 (2019-05-01 – 2019-10-31) from Phase Holographic Imaging.